Novel Research Suggests New Way to Target Mantle Cell Lymphoma Using FOXO1 Inhibitors

Novel Research Suggests New Way to Target Mantle Cell Lymphoma Using FOXO1 Inhibitors

header-info

Preclinical research has shown that mantle cell lymphoma is so critically dependent on the FOXO1 protein that by blocking its activity with an experimental drug, the cancer’s growth may be slowed, according to a new study published by Jang et al in the Journal of Clinical Investigation.